Ishita Pharmaceuticals Acquires 0.85% Stake in Ishita Drugs & Industries
Ishita Pharmaceuticals acquired a 0.85% stake (25,353 shares) in Ishita Drugs & Industries through an open market purchase on September 15, 2025. The transaction marks Ishita Pharmaceuticals' entry as a shareholder in the company. Prior to this, Ishita Pharmaceuticals held no shares. The acquisition complies with SEBI regulations, and the necessary disclosures have been filed with BSE Limited. Ishita Drugs & Industries' total equity share capital remains unchanged at Rs. 29,903,000, divided into 2,990,300 shares with a face value of Rs. 10 each.
*this image is generated using AI for illustrative purposes only.
Ishita Drugs & Industries , a pharmaceutical company, has seen a significant development as Ishita Pharmaceuticals, a related party, acquired a stake in the company. The transaction, which took place on September 15, 2025, marks Ishita Pharmaceuticals' entry as a shareholder in Ishita Drugs & Industries.
Transaction Details
Ishita Pharmaceuticals acquired 25,353 shares of Ishita Drugs & Industries through an open market purchase. Each share has a face value of Rs. 10.00. This acquisition represents 0.85% of the total share capital of the target company.
Impact on Shareholding
| Shareholder | Before Transaction | After Transaction |
|---|---|---|
| Ishita Pharmaceuticals | 0 shares (0.00%) | 25,353 shares (0.85%) |
Prior to this transaction, Ishita Pharmaceuticals held no shares in Ishita Drugs & Industries. Following the acquisition, their total holding stands at 25,353 shares, accounting for 0.85% of the voting rights in the company.
Company Capital Structure
The transaction does not affect the overall equity share capital of Ishita Drugs & Industries, which remains at Rs. 29,903,000.00. This capital is divided into 2,990,300 shares, each with a face value of Rs. 10.00.
Regulatory Compliance
In compliance with SEBI regulations, specifically Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011, Ishita Pharmaceuticals has made the necessary disclosures regarding this acquisition. The company filed the required documentation with the BSE Limited, where Ishita Drugs & Industries is listed under the scrip code 524400.
Market Implications
While this acquisition represents a relatively small percentage of the total shares, it signifies a new relationship between Ishita Pharmaceuticals and Ishita Drugs & Industries. As related parties, this move could potentially lead to closer cooperation or strategic alignment between the two entities in the future.
Investors and market watchers will likely monitor any further developments or transactions between these companies, as well as any potential impact on Ishita Drugs & Industries' operations or market performance.
Historical Stock Returns for Ishita Drugs & Indus
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +0.63% | +6.45% | +3.56% | +3.21% | -1.32% | +294.22% |
15
